Albert Y Liu

Summary

Publications

  1. ncbi request reprint Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men
    Albert Y Liu
    Department of Medicine, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 47:241-7. 2008
  2. pmc HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
  3. pmc Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California2Department of Medicine, University of California, San Francisco
    JAMA Intern Med 176:75-84. 2016
  4. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
  5. pmc The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
    Marc M Solomon
    Gladstone Institutes, San Francisco, CA University of California, San Francisco, San Francisco, CA Projeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil Bridge HIV, San Francisco Department of Public Health, San Francisco, CA Investigaciones Medicas en Salud, Lima, Peru Research Institute for Health Sciences and Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand and Fenway Institute, Fenway Health, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA
    J Acquir Immune Defic Syndr 71:281-6. 2016
  6. pmc Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
    Patricia A Defechereux
    J David Gladstone Institutes, Grant Lab, GIVI, 5th Floor, 1650 Owens Street, San Francisco, 94158, CA, USA
    AIDS Behav 20:1478-88. 2016
  7. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013
  8. pmc Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
    Marc M Solomon
    aThe Gladstone Institutes bUniversity of California cBridge HIV, San Francisco Department of Public Health, San Francisco, USA dInvestigaciones Medicas en Salud eAsociación Civil Impacta Salud y Educación, Lima, Peru fInstituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil gFenway Institute, Fenway Health, Boston, USA hResearch Institute for Health Sciences iDepartment of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand jProjeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil kDesmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa lDivision of Clinical Immunology and Allergy, School of Medicine, University of São Paulo mInstituto de Investigação em Imunologia, CEP 05403 900 Cerqueira Cesar, Sao Paulo, Brazil nNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    AIDS 28:851-9. 2014
  9. pmc Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California San Francisco UCSF, San Francisco, California, United States of America
    PLoS ONE 9:e83736. 2014
  10. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011

Collaborators

Detail Information

Publications20

  1. ncbi request reprint Limited knowledge and use of HIV post- and pre-exposure prophylaxis among gay and bisexual men
    Albert Y Liu
    Department of Medicine, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 47:241-7. 2008
    ..Media reports have suggested substantial levels of community PrEP use despite its unproven effectiveness...
  2. pmc HIV pre-exposure prophylaxis in men who have sex with men and transgender women: a secondary analysis of a phase 3 randomised controlled efficacy trial
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA Department of Medicine, University of California, San Francisco, CA, USA Department of Epidemiology and Biostatistics, University of California, San Francisco, CA, USA Electronic address
    Lancet Infect Dis 14:468-75. 2014
    ..We aimed to estimate the PAF and NNT of participants in the iPrEx (Pre-Exposure Prophylaxis Initiative) trial...
  3. pmc Preexposure Prophylaxis for HIV Infection Integrated With Municipal- and Community-Based Sexual Health Services
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California2Department of Medicine, University of California, San Francisco
    JAMA Intern Med 176:75-84. 2016
    ....
  4. pmc Sexual risk behavior among HIV-uninfected men who have sex with men participating in a tenofovir preexposure prophylaxis randomized trial in the United States
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    J Acquir Immune Defic Syndr 64:87-94. 2013
    ..To evaluate for changes in sexual behaviors associated with daily pill use among men who have sex with men (MSM) participating in a preexposure prophylaxis trial...
  5. pmc The Safety of Tenofovir-Emtricitabine for HIV Pre-Exposure Prophylaxis (PrEP) in Individuals With Active Hepatitis B
    Marc M Solomon
    Gladstone Institutes, San Francisco, CA University of California, San Francisco, San Francisco, CA Projeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil Bridge HIV, San Francisco Department of Public Health, San Francisco, CA Investigaciones Medicas en Salud, Lima, Peru Research Institute for Health Sciences and Department of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand and Fenway Institute, Fenway Health, Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, MA
    J Acquir Immune Defic Syndr 71:281-6. 2016
    ..Pre-exposure prophylaxis (PrEP) with daily oral emtricitabine and tenofovir disoproxil fumarate (FTC/TDF) prevents HIV infection. The safety and feasibility of HIV PrEP in the setting of hepatitis B virus (HBV) infection were evaluated...
  6. pmc Depression and Oral FTC/TDF Pre-exposure Prophylaxis (PrEP) Among Men and Transgender Women Who Have Sex With Men (MSM/TGW)
    Patricia A Defechereux
    J David Gladstone Institutes, Grant Lab, GIVI, 5th Floor, 1650 Owens Street, San Francisco, 94158, CA, USA
    AIDS Behav 20:1478-88. 2016
    ..46; 95 % CI 1.09-1.94). We recommend continuing PrEP during periods of depression in conjunction with provision of mental health services. ..
  7. ncbi request reprint CROI 2013: New tools to understand transmission dynamics and prevent HIV infections
    Susan P Buchbinder
    Bridge HIV, San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 21:47-61. 2013
    ..Fortunately, new strategies are being developed that could substantially reduce new infections globally, such as methods to increase adherence and the use of long-acting antiretroviral agents...
  8. pmc Changes in renal function associated with oral emtricitabine/tenofovir disoproxil fumarate use for HIV pre-exposure prophylaxis
    Marc M Solomon
    aThe Gladstone Institutes bUniversity of California cBridge HIV, San Francisco Department of Public Health, San Francisco, USA dInvestigaciones Medicas en Salud eAsociación Civil Impacta Salud y Educación, Lima, Peru fInstituto de Pesquisa Clinica Evandro Chagas, Fundacao Oswaldo Cruz, Rio de Janeiro, Brazil gFenway Institute, Fenway Health, Boston, USA hResearch Institute for Health Sciences iDepartment of Community Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand jProjeto Praça Onze, Hospital Escola Sao Francisco de Assis, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil kDesmond Tutu HIV Centre and Department of Medicine, University of Cape Town, Cape Town, South Africa lDivision of Clinical Immunology and Allergy, School of Medicine, University of São Paulo mInstituto de Investigação em Imunologia, CEP 05403 900 Cerqueira Cesar, Sao Paulo, Brazil nNational Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA
    AIDS 28:851-9. 2014
    ..Tenofovir disoproxil fumarate (TDF) pre-exposure prophylaxis decreases sexual acquisition of HIV infection. We sought to evaluate the renal safety of TDF in HIV-uninfected persons...
  9. pmc Strong relationship between oral dose and tenofovir hair levels in a randomized trial: hair as a potential adherence measure for pre-exposure prophylaxis (PrEP)
    Albert Y Liu
    Bridge HIV, San Francisco Department of Public Health, San Francisco, California, United States of America Department of Medicine, University of California San Francisco UCSF, San Francisco, California, United States of America
    PLoS ONE 9:e83736. 2014
    ..To evaluate the relationship between dose and tenofovir concentrations in hair, we examined the dose proportionality of tenofovir in hair in healthy, HIV-uninfected adults...
  10. pmc Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco
    Albert Y Liu
    San Francisco Department of Public Health, San Francisco, California, United States of America
    PLoS ONE 6:e23688. 2011
    ..We determined the baseline prevalence of low bone mineral density (BMD) and the effect of TDF on BMD in men who have sex with men (MSM) in a PrEP trial in San Francisco...
  11. pmc Informing Strategies to Build PrEP Capacity among San Francisco Bay Area Clinicians
    Oliver Bacon
    1San Francisco Department of Public Health, San Francisco, CA, USA 2University of California, San Francisco, San Francisco, CA, USA 3San Francisco State University, San Francisco, CA, USA
    J Acquir Immune Defic Syndr . 2016
    ..43-15.76, p=0.01). Desire for further training was associated with concerns about drug resistance (p=0.04) and side effects (p=0.04), and was more common among non-ID specialists. Clinicians favored on-line and in-person training methods...
  12. doi request reprint Successful Implementation of HIV Preexposure Prophylaxis: Lessons Learned From Three Clinical Settings
    Julia L Marcus
    Division of Research, Kaiser Permanente Northern California, 2000 Broadway, 2nd Floor, Oakland, CA, 94612, USA
    Curr HIV/AIDS Rep 13:116-24. 2016
    ..These early implementation experiences demonstrate that PrEP can be successfully delivered across a variety of settings and highlight strategies to streamline PrEP delivery in clinical practice. ..
  13. pmc Sexual Behavior, Risk Compensation, and HIV Prevention Strategies Among Participants in the San Francisco PrEP Demonstration Project: A Qualitative Analysis of Counseling Notes
    J Carlo Hojilla
    Department of Community Health Systems, School of Nursing, University of California, San Francisco, 2 Koret Way, N505, San Francisco, CA, 94143, USA
    AIDS Behav 20:1461-9. 2016
    ..Understanding sexual decision-making and how PrEP is incorporated into existing prevention strategies can help inform future PrEP implementation efforts. ..
  14. pmc Medication adherence among men who have sex with men at risk for HIV infection in the United States: implications for pre-exposure prophylaxis implementation
    Albert Y Liu
    1 Bridge HIV, San Francisco Department of Public Health, San Francisco, California
    AIDS Patient Care STDS 28:622-7. 2014
    ..Counseling strategies to build pill-taking routines and support younger MSM are suggested to maximize the public health impact of PrEP...
  15. pmc Preexposure chemoprophylaxis for HIV prevention in men who have sex with men
    Robert M Grant
    J David Gladstone Institutes, University of California at San Francisco, 1650 Owens St, San Francisco, CA 94158, USA
    N Engl J Med 363:2587-99. 2010
    ..Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition...
  16. ncbi request reprint CROI 2016: Hot Spots in HIV Infection and Advances in HIV Prevention
    Susan P Buchbinder
    University of California San Francisco and San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 24:10-28. 2016
    ..The use of broadly neutralizing antibodies for HIV prevention is a novel and promising approach to be evaluated in efficacy trials. ..
  17. ncbi request reprint CROI 2015: Advances in HIV Testing and Prevention Strategies
    Susan P Buchbinder
    University of California San Francisco and San Francisco Department of Public Health, San Francisco, CA, USA
    Top Antivir Med 23:8-27. 2015
    ..However, consistent viral suppression does not occur in a substantial minority of patients in many clinics, reducing the potential impact of treatment as prevention. ..
  18. pmc High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project
    Stephanie E Cohen
    San Francisco Department of Public Health, San Francisco, CA Department of Medicine, University of California San Francisco, San Francisco, CA Department of Medicine, Miller School of Medicine, University of Miami, Miami, FL DF Net Research, Inc, Seattle, WA Whitman Walker Health Center, Washington, DC and Division of AIDS, National Institutes of Health, Bethesda, MD
    J Acquir Immune Defic Syndr 68:439-48. 2015
    ..Little is known about levels of interest and characteristics of individuals who elect to take PrEP in real-world clinical settings...
  19. ncbi request reprint CROI 2014: New tools to track the epidemic and prevent HIV infections
    Susan P Buchbinder
    University of California San Francisco, San Francisco, CA, USA
    Top Antivir Med 22:579-93. 2014
    ..As adherence is a crucial determinant of PrEP efficacy, long-acting PrEP agents are promising approaches being tested. ..
  20. ncbi request reprint Preexposure prophylaxis for HIV: unproven promise and potential pitfalls
    Albert Y Liu
    HIV Research Section, San Francisco Department of Public Health, San Francisco, Calif 94102, USA
    JAMA 296:863-5. 2006